Catherine Alix-Panabières, Director of the Laboratory of Rare Human Circulating Cells and Professor of Universities – Hospital Practitioner at Montpellier University Hospital, shared a post on LinkedIn:
“Do you want to learn more about the history of circulating tumor cell (CTC) lines and xenograft models, developed over the past years from CTCs isolated directly from cancer patients – and their biological insights, clinical relevance, and translational applications?
This new review is for you !!!! Good Reading !!!!
Proud to highlight the outstanding work of these women scientists from the Liquid Biopsy LCCRH Lab – Laboratoire Cellules Circulantes Rares Humaines (CHU de Montpellier), whose dedication and scientific excellence continue to advance translational oncology research.
Our study has just been published in the excellent Journal of Experimental and Clinical Cancer Research (IF 12.8):
“Reconstructing the Metastatic Journey: Functional Circulating Tumor Cells and Disseminated Tumor Cells-based Models for Translational Oncology.”
A comprehensive overview of how functional CTC/DTC models help us better understand metastasis biology and move closer to improving patient care.
The article is open access – feel free to read and share it!”
Other articles featuring CTC on OncoDaily.